SCHEMBL19863076

SCHEMBL19863076

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc4c5ccccc5oc4c4c3c3ccccc3n4-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.37
TSHR P16473 5/20 0.37
ALDH1A1 P00352 6/20 0.35
KDM4E B2RXH2 3/20 0.35
POLB P06746 2/20 0.35
HPGD P15428 1/20 0.35
LMNA P02545 4/20 0.35
HSD17B10 Q99714 3/20 0.35
MAPK1 P28482 2/20 0.35
NPSR1 Q6W5P4 2/20 0.34
KMT2A Q03164 6/20 0.34
MEN1 O00255 5/20 0.34
USP2 O75604 1/20 0.34
HTT P42858 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
GAA P10253 1/20 0.32
CSF1R P07333 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18594134 0.96 MAPT (0.36) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL18594417 0.95 MAPT (0.38) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL19863078 0.95 MAPT (0.35) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL18594352 0.94 MAPT (0.37) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL19863060 0.93 MAPT (0.36) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL18594346 0.92 MAPT (0.35) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL18593690 0.92 MAPT (0.36) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL19863080 0.91 MAPT (0.36) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL19863083 0.91 MAPT (0.36) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL18594139 0.91 MAPT (0.37) MAPTTSHRALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MAPT 746/4885TSHR 3741/4885ALDH1A1 242/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MAPT 746/4885TSHR 3741/4885ALDH1A1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.